Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The mitogenic ovarian steroid hormone 17β-estradiol (E2) is related with development of Estrogen Receptor Positive (ER+) breast cancer, and ER signifies a major therapeutic target for endocrine therapy. In addition to the ER dependent signal transduction, cellular oxidative metabolism of the ER ligand E2 produces numerous metabolites with pleotropic growth modulatory effects on breast cancer cells, providing appreciated leads for novel therapeutic approach.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi